Open AccessPrognostic Factors in Aggressive Non‐Hodgkin's Lymphomas
Author(s) -
Nicolaides Costas,
Dimou Sofia,
Pavlidis Nicholas
Publication year - 1998
Publication title -
the oncologist
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.176
H-Index - 164
eISSN - 1549-490X
pISSN - 1083-7159
DOI - 10.1634/theoncologist.3-3-189
Subject(s) - medicine , lymphoma , disease , oncology , aggressive lymphoma , chemotherapy , non hodgkin's lymphoma , hodgkin lymphoma , rituximab
Aggressive non‐Hodgkin's lymphoma (NHL) is a biologically heterogeneous disease that can be cured with aggressive chemotherapy treatment. Different clinical, biological, cellular and molecular features have been identified as having prognostic significance on the outcome of NHL patients. The knowledge of these prognostic features can be used in everyday practice in order to predict the prognosis of every new NHL patient and tailor his or her treatment accordingly.